SCHEMBL26420740

SCHEMBL26420740

COc1cnc(Oc2c(Cl)cc(N)cc2Cl)cc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.48
KDM4E B2RXH2 3/20 0.43
POLB P06746 1/20 0.43
P2RX3 P56373 2/20 0.36
P2RX2 Q9UBL9 2/20 0.36
KEAP1 Q14145 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
BRCA1 P38398 1/20 0.35
HBB P68871 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NNMT P40261 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
GAA P10253 1/20 0.34
NPC1 O15118 1/20 0.34
FYN P06241 4/20 0.34
PDE5A O76074 1/20 0.34
DHFR P00374 1/20 0.34
SCN9A Q15858 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663370 0.84 MAPT (0.47) MAPTKDM4EPOLBP2RX3P2RX2
SCHEMBL29965505 0.84 MAPT (0.47) MAPTKDM4EPOLBP2RX3P2RX2
SCHEMBL29965587 0.82 MAPT (0.46) MAPTKDM4EPOLBP2RX3P2RX2
SCHEMBL23663261 0.82 MAPT (0.46) MAPTKDM4EPOLBP2RX3P2RX2
SCHEMBL23691429 0.81 MAPT (0.45) MAPTKDM4EPOLBP2RX3P2RX2
SCHEMBL23691262 0.80 MAPT (0.41) MAPTPOLBMEN1ALDH1A1KMT2A
SCHEMBL23663408 0.79 MAPT (0.66) MAPTKDM4EPOLBMEN1ALDH1A1
SCHEMBL23691576 0.78 MAPT (0.42) MAPTPOLBP2RX3P2RX2ALDH1A1
SCHEMBL23663212 0.77 MAPT (0.47) MAPTKDM4EPOLBMEN1ALDH1A1
SCHEMBL29965305 0.77 MAPT (0.47) MAPTKDM4EPOLBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB MAPT 112/4885KDM4E 4755/4885POLB 3878/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.